Floatz logo

Therapeutic Asset Ratings

414 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Kras Tcr-Transduced Pbl
Colorectal Cancer
National Cancer Institute (NCI)P2CCC (50)
Pirfenidone
Colorectal Cancer
Guoxiang CaiP2CCC (50)
Riluzole
Colorectal Cancer
University of California, IrvineP2CCC (50)
Shr-8068
Colorectal Cancer
Fudan UniversityP2CCC (50)
Tisleizumab
Colorectal Cancer
Tao ZhangP2CCC (50)
Vactosertib
Colorectal Cancer
David WaldP2CCC (50)
Denosumab
Colorectal Cancer
Redx Pharma LtdP2CCC (48)
Dkn-01
Colorectal Cancer
Leap Therapeutics, Inc.P2CCC (48)
FAPI74
Colorectal Cancer
SOFIEP2CCC (48)
Mycobacterium Obuense
Colorectal Cancer
AIO-Studien-gGmbHP2CCC (48)
Ompenaclid
Colorectal Cancer
Inspirna, Inc.P2CCC (48)
Prolgolimab
Colorectal Cancer
Blokhin's Russian Cancer Research CenterP2CCC (48)
rxc004
Colorectal Cancer
Redx Pharma LtdP2CCC (48)
GEH300079 (68Ga)
Colorectal Cancer
GE HealthcareP2/3CCC (48)
Grt-C903
Colorectal Cancer
National Cancer Institute (NCI)P1/2CCC (48)
Grt-R904
Colorectal Cancer
National Cancer Institute (NCI)P1/2CCC (48)
hr070803
Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd.P2/3CCC (48)
Jab-21822
Colorectal Cancer
Jian LiP1/2CCC (48)
Osimertinib
Colorectal Cancer
Genentech, Inc.P1/2CCC (48)
Retifanlimab
Colorectal Cancer
National Cancer Institute (NCI)P1/2CCC (48)
Rintatolimod
Colorectal Cancer
Roswell Park Cancer InstituteP2CC (47)
Agen1423
Colorectal Cancer
Weill Medical College of Cornell UniversityP2CC (46)
Aguix
Colorectal Cancer
Brigham and Women's HospitalP2CC (46)
Aipalolitovorelizumab
Colorectal Cancer
Yanqiao ZhangP2CC (46)
All Trans Retinoic Acid
Colorectal Cancer
University of Texas Southwestern Medical CenterP2CC (46)
Showing 101 to 125 of 414 assets
PreviousPage 5 of 17Next